Isomerase Therapeutics expands presence at Chesterford Research Park
November 1st, 2014--Cambridge
Isomerase Therapeutics Ltd. announces that it has expanded its presence at Chesterford Research Park by taking on an additional 1,966 square feet of space in the Science Village and hiring and doubling their research staff.
CEO of Isomerase Therapeutics, Dr Matt Gregory commented "In the last year we have increased our current collaboration partners to five pharma and biotech companies. The income from this is enabling us to reinvest in the company by increasing our laboratory space, buying new equipment and by hiring top quality scientists with a wide range of expertise. This expansion is allowing us to give our partners the very best support in drug discovery and development."
Dr Steven Moss, CSO of Isomerase Therapeutics added "We are very pleased with the continuing expansion of Isomerase. The facility we have here is high quality and we have recruited some excellent researchers. "
For further information, please contact Dr Matt Gregory via our contact page.